Multiparametric mri
Multiparametric mri has been studied in 2 papers since 2026: none in people yet, 2 reviews; 2 in the past year. No study of it in people or animals has been published yet. The newest paper, Oct 27, 2026: “The future of prostate cancer screening: from prostate-specific antigen to smart, risk-adapted pathways”.
2 papers study it2 findingsUpdated
2 new papers in 30 daysSee all 2 papers on multiparametric mri
What did studies of multiparametric mri find?
2Studies of multiparametric mri measured 2 outcomes: Detection of clinically significant prostate cancer and Detection of aggressive prostate tumors.
Detection of clinically significant prostate cancer
upin humans1
1 study
Detection of clinically significant prostate cancer
upin humans1
Multiparametric mri improves detection of clinically significant prostate cancer in humans (through targeted biopsy).
“mpMRI offers strong rule-in performance, improving detection of clinically significant prostate cancer (csPCa) through targeted biopsy”
Reviewthrough targeted biopsyprostatemales
Current opinion in urology
Detection of aggressive prostate tumors
upin humans1
1 study
Detection of aggressive prostate tumors
upin humans1
Multiparametric mri increases detection of aggressive prostate tumors in humans (combined with MRI-targeted biopsy).
“combined with MRI-targeted biopsy, enhances detection of aggressive tumors while reducing identification of indolent disease.”
Reviewcombined with MRI-targeted biopsyprostate
Early Detection of Prostate Cancer: Advances in Screening, Biomarkers, and Imaging Strategies
Current oncology reports